CorVista System with PH Add-On vs Merge PACS

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by CorVista Health
VS
by Merative

AI Verdict

Tool A is a specialized AI diagnostic platform for cardiovascular diseases, providing rapid, non-invasive assessments at the point of care. Tool B, in contrast, is an enterprise-level PACS designed for managing imaging data, streamlining radiology workflows, and integrating various third-party AI applications. While both operate in the cardiology and radiology AI domains, Tool A offers specific diagnostic capabilities, whereas Tool B provides the infrastructure for imaging management and AI integration.

Choose CorVista System with PH Add-On if…

Choose CorVista System with PH Add-On if your primary need is rapid, non-invasive, point-of-care diagnostic assessment for coronary artery disease and pulmonary hypertension. This tool is ideal for quickly obtaining initial insights without radiation, contrast agents, or extensive patient preparation, delivering results within minutes to inform immediate clinical decisions.

View CorVista System with PH Add-On →

Choose Merge PACS if…

Choose Merge PACS if you require an enterprise-level solution for comprehensive imaging management, workflow optimization, and multi-modality diagnostic interpretation across a multi-site health system. This platform is best suited for consolidating diverse imaging data, integrating third-party AI applications, and enhancing diagnostic workflows with flexible deployment options and robust EMR/EHR integration.

View Merge PACS →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature CorVista System with PH Add-On Merge PACS
Pricing Unknown Contact vendor
Deployment Cloud-based, point-of-care system. On-premise, Cloud, Hybrid
FDA Status 1 AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

CorVista System with PH Add-On

The CorVista System is designed for point-of-care with an emphasis on ease of use, featuring an iPad-sized interface and allowing medical assistants to conduct tests and deliver rapid results via a secure web portal. While Merge PACS aims for efficiency in complex radiology workflows, its enterprise nature can lead to a steeper learning curve and implementation challenges for some users.

Clinical Value

CorVista System with PH Add-On

The CorVista System provides direct diagnostic value as an FDA-cleared, non-invasive tool for rapid assessment of coronary artery disease and pulmonary hypertension, with high negative predictive values for ruling out these conditions. Merge PACS, while enhancing diagnostic workflows and integrating third-party AI, primarily serves as an infrastructure for imaging data management rather than a direct diagnostic tool itself.

Pricing & Value

CorVista System with PH Add-On

The CorVista System explicitly highlights its 'medical-device-as-a-service' model, requiring no significant capital investment and demonstrating economic benefits through reduced need for more expensive care. While Merge PACS has historically offered flexible 'pay-per-study' options, CorVista's current emphasis on cost-effectiveness and accessibility for point-of-care diagnostics provides a clearer value proposition for its target market.

Enterprise Readiness

Merge PACS

Merge PACS is explicitly an 'enterprise-level Picture Archiving and Communication System' designed for multi-site health systems, offering robust integration with EMR/EHR, RIS, HIS, and VNA systems, and flexible deployment options (on-premise, cloud, hybrid). While CorVista System is cloud-based and scalable for distributed care, its focus is on a specific point-of-care diagnostic function rather than comprehensive enterprise imaging management.

Innovation

CorVista System with PH Add-On

The CorVista System represents a significant innovation with its non-invasive, point-of-care AI diagnostic platform that eliminates the need for radiation, contrast agents, injections, fasting, or exercise for CAD and PH assessment. Its 'Breakthrough Device' designation for the PH Add-On further underscores its novel approach to diagnosis. Merge PACS, while offering advanced features like AI integration and enhanced workflows, focuses more on optimizing existing PACS functionalities rather than introducing a fundamentally new diagnostic method.

Support & Docs

Merge PACS

Merative, the company behind Merge PACS, provides a comprehensive support portal with various contact channels for technical support, provisioning, and account services, along with extensive product documentation including DICOM Conformance Statements and system manuals. While CorVista System has contact information and mentions 'Instructions for Use', Merative's established and multi-faceted support infrastructure appears more robust for an enterprise solution.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature CorVista System with PH Add-On Merge PACS
Name CorVista System with PH Add-On Merge PACS
Description The CorVista System with PH Add-On is an FDA-cleared, non-invasive, point-of-care AI diagnostic platform for rapid assessment of coronary artery disease and pulmonary hypertension using machine-learned algorithms. Merative Merge PACS is an enterprise-level Picture Archiving and Communication System (PACS) that streamlines radiology workflows, consolidates imaging data, and integrates AI insights across multi-site health systems. It supports multi-modality diagnostic interpretation with flexible deployment options.
Company Analytics for Life Merative
Key Diagnostic Approach Non-invasive cardiovascular diagnostics using machine-learned algorithms; no radiation, contrast agents, injections, fasting, or exercise required. Multi-modality diagnostic interpretation with AI integration and enhanced diagnostic workflows (e.g., Synchronized Priors Scrolling for mammography, image fusion).
Primary Focus Rapid assessment of coronary artery disease and pulmonary hypertension at point-of-care. Streamlining radiology workflows, consolidating imaging data, and enterprise-wide image management.

Videos

Demos, reviews, and walkthroughs featuring CorVista System with PH Add-On and Merge PACS.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The CorVista System with PH Add-On is an FDA-cleared, non-invasive, point-of-care AI diagnostic platform for rapid assessment of coronary artery disease and pulmonary hypertension. In contrast, Merge PACS is an enterprise-level Picture Archiving and Communication System (PACS) that streamlines radiology workflows and consolidates imaging data across multi-site health systems, integrating AI insights for multi-modality diagnostic interpretation.
The CorVista System analyzes cardiac and hemodynamic signals non-invasively at the point-of-care, requiring no radiation, contrast agents, injections, fasting, or exercise. Merge PACS, on the other hand, focuses on managing, archiving, and interpreting existing imaging data from various modalities, enhancing diagnostic workflows.
The CorVista System utilizes machine-learned algorithms for its core diagnostic function, analyzing physiological signals to indicate the likelihood of specific cardiovascular diseases. Merge PACS integrates AI by providing single worklist access to third-party AI applications, enhancing diagnostic workflows and offering real-time analytics.
While the CorVista System provides analysis results via a secure web portal, Merge PACS is designed for enterprise-wide image management and consolidation, offering integration with EMR/EHR, RIS, HIS, and VNA systems. Merge PACS also supports customizable worklists for multiple specialties and secure web-based access for remote reading.
The CorVista System offers patients a non-invasive diagnostic experience for CAD and PH, avoiding radiation, contrast agents, injections, fasting, or exercise, with rapid results available within minutes. Merge PACS primarily benefits patients indirectly by streamlining diagnostic workflows, consolidating imaging data, and integrating AI insights for more efficient and potentially more accurate interpretations by physicians.

Backers

Who funded each tool's parent company.

Merge PACS

AI Tool Finder
AI-powered search. Results may not be comprehensive.